Acid-labile polysaccharide prodrug via lapatinib-sensitizing effect substantially prevented metastasis and postoperative recurrence of triple-negative breast cancer
Author:
Affiliation:
1. National Engineering Research Center for Biomaterials
2. Sichuan University
3. Chengdu
4. China
5. Center for Molecular Science and Engineering
6. College of Science
7. Northeastern University
8. Shenyang 110819
Abstract
Co-delivery of lapatinib and Dox by polysaccharide prodrug prevented metastasis and recurrence of triple-negative breast cancer (TNBC) that is usually insensitive to endocrine and molecular targeted therapy.
Funder
National Natural Science Foundation of China
China Association for Science and Technology
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science
Link
http://pubs.rsc.org/en/content/articlepdf/2020/NR/D0NR03395B
Reference49 articles.
1. Triple-Negative Breast Carcinoma
2. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
3. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
4. Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Therapeutic sponge prevents postoperative breast cancer recurrence by sustainably dissociating into CD44-targeted nanoplatform;Nano Research;2023-08-05
2. Recent advances in pH/enzyme-responsive polysaccharide-small-molecule drug conjugates as nanotherapeutics;Carbohydrate Polymers;2023-07
3. Membrane fusion-mediated delivery of small-molecule HER2 tyrosine kinase inhibitor for effective tumor chemosensitization;Journal of Controlled Release;2023-05
4. Recent Advances in Boosting EGFR Tyrosine Kinase Inhibitors-Based Cancer Therapy;Molecular Pharmaceutics;2023-01-02
5. Preparation and characterization of photo-oxidative dual-crosslinked chitosan/hyaluronic acid hydrogels;Reactive and Functional Polymers;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3